The Health Section develops policy positions that promote biomedical innovation and represent the best interests of BIO member companies with a direct interest in human health. Among the priority issues the Health Section focuses on are matters affecting the healthcare-related regulatory and reimbursement climate, pandemic and biodefense preparedness, publicly-funded scientific research, and personalized medicine. The Health Section is managed by a Section governing body and recommends members to sit on BIO's Board of Directors.
Staff Contact: John Taylor
|
|
Chairman
Stephen A. Sherwin, MD
Chairman
Ceregene, Inc
|
Immediate Past Chairman
Joshua Boger, PhD
Founder and CEO (retired)
Vertex Pharmaceuticals Incorporated
|
Vice Chairman
H. Thomas Watkins
President & CEO
Human Genome Sciences, Inc
|
Secretary
Rachel K. King, MBA
President & CEO
GlycoMimetics, Inc
|
Member
Jean-Jacques Bienaime
President & CEO
BioMarin Pharmaceutical, Inc
|
Member
Hans Bishop
President, Specialty Medicine
Bayer HealthCare Pharmaceuticals, Inc
|
Member
John L. Bishop
Chief Executive Officer
Cepheid
|
Member
Rainer Boehm, MD
Executive Vice President, North American Region Head, Novartis Oncology
Novartis Oncology
|
Member
Fabrizio Bonanni, Dr. Chem.
Executive Vice President, Operations
Amgen Inc
|
Member
Alexis Borisy
Founder, President, CEO (former)
CombinatoRx, Incorporated
|
Member
Francis V. Brown
CEO, Inflammation & Immunology Division, and Sr. Vice President, Global Project
Celgene Corporation
|
Member
Ian T. Clark
Head of Global Product Strategy & Chief Marketing Officer
Roche Pharma Division
|
Member
Lonnel Coats
President & COO
Eisai, Inc
|
Member
Ron Cohen, MD
President & CEO
Acorda Therapeutics, Inc
|
Member
N. Anthony Coles, MD, MPH
President & CEO
Onyx Pharmaceuticals, Inc
|
Member
Robert E. Conway, MBA, CPA
Chief Executive Officer
Array BioPharma, Inc
|
Member
Geoffrey F. Cox, PhD
Chairman, President & CEO
GTC Biotherapeutics, Inc
|
Member
Douglas A. Doerfler
President & CEO
MaxCyte, Inc
|
Member
Greg Duncan
President of US & Canada Operations
UCB, Inc
|
Member
Deborah Dunsire, MD
President & CEO
Millennium: The Takeda Oncology Company
|
Member
Fereydoun Firouz
President & CEO
EMD Serono, Inc
|
Member
Paul H. Fischer, PhD
President & CEO
GenVec, Inc
|
Member
Colin A. Goddard, PhD
Chief Executive Officer
OSI Pharmaceuticals, Inc
|
Member
David F. Hale
Chairman
Micromet, Inc
|
Member
Paul J. Hastings
President & CEO
OncoMed Pharmaceuticals, Inc
|
Member
Russell H. Herndon
President & CEO
Hydra Biosciences, Inc
|
Member
Steven H. Holtzman
Chairman & CEO
Infinity Pharmaceuticals, Inc
|
Member
Daniel M. Junius
President & CEO
ImmunoGen, Inc
|
Member
Scott Koenig, MD, PhD
President & CEO
MacroGenics, Inc
|
Member
Thomas P. Koestler, PhD
Executive VP, and President, Schering-Plough Research Institute
Schering-Plough Corporation
|
Member
John M. Leonard, MD
Vice President, Global Pharmaceuticals, R&D
Abbott
|
Member
Gregory T. Lucier
Chairman & CEO
Life Technologies Corporation
|
Member
John Maraganore, PhD
Chief Executive Officer
Alnylam Pharmaceuticals, Inc
|
Member
Thomas P. Mathers
President & CEO
Peptimmune, Inc
|
Member
Gordon C. McCauley
President & CEO
Allon Therapeutics, Inc
|
Member
Russell M. Medford, MD, PhD
President & CEO
Salutria Pharmaceuticals, LLC
|
Member
Steven J. Mento, PhD
President, CEO & Co-Founder
Conatus Pharmaceuticals, Inc
|
Member
John F. Milligan, PhD
President & COO
Gilead Sciences, Inc
|
Member
Arlene M. Morris
President & CEO
Affymax, Inc
|
Member
James C. Mullen
President & CEO
Biogen Idec, Inc
|
Member
Thomas B. Okarma, PhD, MD
President, CEO & Director
Geron Corporation
|
Member
Robert L. Parkinson, MBA
Chairman & CEO
Baxter International Inc
|
Member
Steven M. Paul, MD
Executive VP, Science & Technology, and President, Lilly Research Laboratories
Eli Lilly & Company
|
Member
Kristine Peterson
Chief Executive Officer
Valeritas, Inc
|
Member
Wayne Pisano
President & CEO
sanofi pasteur
|
Member
Richard Pops
Chairman, President & CEO
Alkermes, Inc
|
Member
David E. I. Pyott
Chairman & CEO
Allergan, Inc
|
Member
William Rhodes
Worldwide President, BD Biosciences
BD
|
Member
Timothy C. Rodell, MD
Chief Executive Officer & President
GlobeImmune, Inc
|
Member
Steven Ryder, MD, FACP
President
Astellas Pharma US
|
Member
George Scangos
President & CEO
Exelixis, Inc
|
Member
Mark W. Schwartz, PhD
President & CEO (former)
Bayhill Therapeutics, Inc
|
Member
Mark Skaletsky
President & CEO
Fenway Pharmaceuticals, Inc
|
Member
Ellen Strahlman, MD
Senior Vice President and Chief Medical Officer
GlaxoSmithKline, Inc
|
Member
Kim Taylor
President and CEO, Centocor Ortho Biotech, Inc.
Johnson & Johnson
|
Member
Henri A. Termeer
Chairman, President & CEO
Genzyme Corporation
|
Member
Peter A. Thompson, MD
Co-Founder
Trubion Pharmaceuticals, Inc
|
Member
Harold E. Van Wart, PhD
President, CEO & Director
Metabolex, Inc
|
Member
Tony Zook
President
AstraZeneca, Plc
|
Printer Friendly